tm logo
IWYND
Live/Registered
REGISTERED

on 01 Feb 2022

Last Applicant/ Owned by

Astraallén

Södertälje

SE

SE-15185

Serial Number

88689185 filed on 12th Nov 2019

Registration Number

6631063 registered on 01st Feb 2022

in the Principal Register

Correspondent Address

Cara M. Kearney

AstraZeneca Pharmaceuticals LP

1800 Concord Pike, A2C

Wilmington DE 19850-5437

Filing Basis

1. intent to use

Disclaimer

NO DATA

IWYND

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Mark Details


Serial Number

No 88689185

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
01st Feb 2022REGISTERED-PRINCIPAL REGISTER
28th Dec 20211(B) BASIS DELETED; PROCEED TO REGISTRATION
28th Dec 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27th Dec 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
27th Dec 2021EXTENSION 2 GRANTED
14th Dec 2021EXTENSION 2 FILED
14th Dec 2021TEAS EXTENSION RECEIVED
22nd Nov 2021NOTICE OF ALLOWANCE CANCELLED
22nd Nov 2021TEAS DELETE 1(B) BASIS RECEIVED
22nd Jul 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED